Panjini M Sivanna, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 3001 Sanford Pkwy, Thief River Falls, MN 56701 Phone: 218-683-2725 |
News Archive
According to a new report by iData Research, the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010.
Opexa Therapeutics, Inc., a biotechnology company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company is rebranding its leading MS therapy with the new name Tcelna. The product, previously known as Tovaxin, will now be known as Tcelna as the company positions itself towards the treatment of patients with Secondary Progressive MS (SPMS).
Last month, three states – Virginia, South Dakota, and Connecticut – joined the ranks of more than a dozen others that have legalized marijuana – also known as cannabis – for recreational use. Yet, despite these changing laws and growing social acceptance of the drug, a new study finds that use is still lower among cancer patients.
AHF's Magic Johnson 'Testing America' Tour, a six month, 48 state national cross country HIV testing tour, arrives in Wilmington, Delaware tomorrow and will offer free HIV testing, along with local partner AIDS Delaware from 10:00 AM to 2:00 PM in Rodney Square, 2 East 11th St. across from the DuPont Building.
A new brain chemical test that predicts which patients with heart attack symptoms are at higher risk of dying is paradoxically not being used in younger, healthier patients who could benefit the most from the prognostic information provided by this test
› Verified 2 days ago